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Synopsis: Over-diagnosis of papilloedema is common.  Fundus photographic screening is highly 
sensitive for papilloedema detection; however, we found rates of false positive papilloedema 
diagnosis on fundus photography of 7-21% in hospital and community patient samples respectively. 
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ABSTRACT 
Background: Overdiagnosis of papilloedema is common and carries significant potential for 
morbidity from over-investigation and over-treatment.  We aimed to determine the community 
prevalence of false positive diagnosis of papilloedema (FPE) on fundus imaging. 
Methods: We evaluated fundus images from a community cross-section of 198 12-14-year-olds from 
the Avon Longitudinal Study of Parents and Children (ALSPAC) longitudinal cohort study database 
and patient images from our hospital departmental database with and without papilloedema. We 
asked clinicians, in isolation, to rate the subjects as a forced-choice task to “papilloedema” or “not-
papilloedema” based on the fundus images alone.  Raters comprised (i) 4 neuro-ophthalmologists, 
(ii) 4 ophthalmologists, (iii) 4 neurologists and (iv) 4 emergency medicine physicians.  
Results: The prevalence of FPE in the ALSPAC population, defined as images mistaken as 
papilloedema by χ% of raters (Pχ) varied from P100=0% to P50=21.3±3.9%. In the hospital population, 
there was a lower rate of FPE, P50=7.1±10.8%.  Sensitivity for papilloedema detection approached 
100%, though 3 raters incorrectly labelled the same patient with unilateral disc swelling as normal, 
all other cases were detected by all raters.   
Conclusions: Fundus photography assessment in isolation is highly sensitive but poorly specific for 
papilloedema detection. Using this method to screen the general population has significant potential 
for harm as overdiagnosis occurs, even in the hands of experienced clinicians.  
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INTRODUCTION 
On 15th July, 2016 Honey Rose, an optometrist in Suffolk, UK, was convicted of gross-negligence 
manslaughter for failing to detect 8 year old Vincent Barker’s papilloedema in February 2012.  
Although she was subsequently cleared on appeal, the case has had a significant effect on UK 
optometric and ophthalmic practice [1-3].  In this case, Honey Rose conducted a routine sight-test 
examination of Vincent Barker, which involved direct ophthalmoscopy and fundus photography [1].  
She reported that direct ophthalmoscopy was unsuccessful because of photophobia and fundus 
photographs demonstrating papilloedema were obtained, but Ms Rose accidentally viewed the 
wrong images, incorrectly concluding that the fundus appearance was normal [1].  Vincent Barker 
died 5 months later, in July 2012, from hydrocephalus [1]. 
Since the conviction of Honey Rose, neuro-imaging requests and outpatient referrals for 
papilloedema have increased [2, 3].  The Honey Rose case centred around the use of fundus 
photography for papilloedema detection.  Fundus photography is routinely used in most UK 
optometric practices and has been advocated to improve posterior segment evaluation [4].     
Because papilloedema may be the presenting feature of life-threatening conditions, its diagnosis 
often precipitates an urgent hospital admission, brain imaging and lumbar puncture [5].  However, it 
is often over-diagnosed putting patients through unnecessary treatment and invasive investigations 
[2, 6].  False positive diagnosis of papilloedema (FPE) may be caused by an anomalous optic disc 
appearance, termed pseudo-papilloedema [7], or misinterpretation of the fundus appearance.   
Outpatient referrals of patients with suspected papilloedema are common in UK and USA, but few of 
these patients are diagnosed with papilloedema [2, 8], suggesting that the prevalence of FPE is much 
higher than that of papilloedema.   
The prevalence of optic disc drusen (ODD), which are one cause of pseudo-papilloedema, was 
0.035% in a clinical study and up to 2% in cadaveric studies [9, 10].  The prevalence of FPE on fundus 
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photographic screening by a single neuro-ophthalmologist of a morbidly obese population 
undergoing bariatric surgery was up to 2% [11].  The prevalence of FPE in the general population and 
comparison of accuracy between different specialists has not previously been reported.   
We aimed to investigate the prevalence of FPE on fundus images in a community sample of 
unselected children. 
METHODS 
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee.  The study 
protocol was approved by the hospital trust Research and Development Department and conformed 
to the tenets of the Declaration of Helsinki.   
Participants providing images  
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal birth cohort study of 
children born to mothers resident in Avon, UK who had an estimated delivery date between April 1, 
1991 and December 31, 1992, including approximately 72% of eligible pregnant women [12].  The 
ALSPAC study website contains details of all the data that is available through a fully searchable data 
dictionary at http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/.  Informed 
consent was obtained from all subjects and parents/guardians.  Subjects included were all aged 
between 11.8 and 14.2 years at the time of the study visit.  For the purposes of this study, the 
ALSPAC cohort was assumed to be representative of the general population.   
Patient images were obtained from the hospital eye department fundus photographic database.  
Participant information 
Cross-sectional data were collected from children at age 12-14 years. Demographic information 
collected included: age, gender, maternal-reported ethnicity socio-economic status.  Socio-economic 
status was categorised using the highest value for parental employment from both parents 
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(Standard Occupational Classification).  The study visit included: autorefraction using a Canon R50 
autorefractor (Canon Medical Systems, Melville, NY); best corrected LogMAR visual acuity (BCVA), 
height, weight and body fat percentage.  Height was measured with shoes and socks removed using 
a Harpenden stadiometer (Holtain Ltd, Crymych, Pembs, United Kingdom) to the nearest 0.1 cm, and 
weight was measured by using a Tanita TBF 305 body-fat analyzer and weighing scales (Tanita UK 
Ltd, Yewsley, Middlesex, United Kingdom).  BMI was calculated as weight (kilograms)/height (meters 
squared).  To screen for health problems, one year after the images were taken, parents and 
guardians were asked to report on the health of the subject over the previous year. 
For hospital patients, clinical information, including the presence or absence of papilloedema, was 
derived from retrospective analysis of the electronic patient records and paper charts where 
necessary. 
Gold Standard Determination of Papilloedema vs Not Papilloedema 
Our main aim was to determine the prevalence of FPE.  There is no gold standard test to exclude 
papilloedema, although options include fundus fluorescein angiography and lumbar puncture, both 
of which are invasive and would be unethical to perform in a large community sample such as the 
ALSPAC database.   
In children the main causes of papilloedema are intracranial mass lesions, which have an incidence 
of 2-4/100,000 and idiopathic intracranial hypertension, which is less frequent than the adult 
incidence of 0.9/100,000 [13, 14]. The probable number of participants with papilloedema in the 
ALSPAC cohort was close to zero (99% confidence interval 0.001-0.02 of 150 participants assuming a 
frequency of 4/100,000) and for confirmation of this, we reviewed the responses about the 
children’s health, given in parent-completed questionnaires sent out approximately a year after the 
children had their fundus photographs taken.  We therefore assumed that all cases in which 
papilloedema was called in the ASPAC community sample were FPE. 
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Gold standard for the hospital patients was taken as clinical diagnosis.  
Fundus Images 
ALSPAC images were 45° digital retinal images centered on the macula acquired using a Topcon 
nonmydriatic retinal camera (Topcon TRC-NW6s, Topcon Technologies, Paramus, NJ) fitted with a 
Nikon D1X camera (Nikon, Tokyo, Japan).  Images were available for 3350 ALSPAC participants 
attending a multidisciplinary data collection session.  All images were reviewed by two authors (RB 
and CW).  Bilateral images from 150 patients were selected at random from the ALSPAC database.  
To assess intra-observer correlation, a random selection of 10 bilateral images was duplicated.   
Patient fundus images were all acquired on a Topcon TRC-50DX (Type 1A) Mydriatic Retinal Camera 
(with Nikon D300) after pharmacologic dilatation.  Bilateral fundus images from 28 patients without 
papilloedema and 10 patients with papilloedema were randomly selected from the Eye Department 
fundus photographic database.  Only images centered on the macula were included, so that they 
were in the same format as the ALSPAC images.  
Images were excluded when the image quality was rated as inadequate to assess optic disc swelling 
by RB and JH. 
Assessment of fundus photographs 
We conducted a prospective assessment in groups of 4 senior (UK Consultant level) physicians.  The 
groups of physicians were: neuro-ophthalmologists (NO), ophthalmologists (O), neurologists (N) and 
emergency medicine physicians (EM).  We presented ALSPAC and patient images together in a 
forced choice task where we required raters to assign fundus photos to papilloedema or not 
papilloedema groups, based on the photographic appearance alone.  Physicians were not told the 
source of the images and were masked to any clinical details because they were only shown fundus 
images in isolation and in a random order with community and hospital images mixed together. 
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Sample size 
Sample size was calculated as previously described for observational studies as 
𝑍2𝑃(1−𝑃)
𝑑2
 [15], where 
Z is normal statistic for the level of confidence (1.96 for 95%), d is the level of precision required (set 
to half the prevalence) and P is the expected prevalence (published FPE rates are 2-12.5% [11, 16]).  
To detect a 10% rate of FPE with 95% confidence, requires n=138.  A 5% rate of FPE requires n=291.  
Preliminary discussions suggested that more than 200 images would deter clinicians from rating the 
images and we therefore elected to present 150 ALSPAC images. 
Statistical analysis 
Statistical analysis was performed in SPSS 21 (IBM Corp. Armonk, NY), except for free marginal kappa 
which was calculated as previously described to assess inter-rater reliability 
(http://justusrandolph.net/kappa/) [17].  Intra-rater agreement was not assessed because only 10 
images were repeated and none were identified as papilloedema.  Unless otherwise specified, 
means are displayed ± standard error of the mean.  Confidence intervals (CI) for proportions were 
calculated using normal approximation to the binomial distribution or the binomial distribution 
when the proportion mean and variance were greater than 10.  .  Specificity (false positives 
compared to true negatives) was assessed by modelling the proportion of true negative responses in 
the ALSPAC community sample and hospital images without papilloedema using Generalised 
Estimating equations with a binomial model with logit identity function and an exchangeable 
correlation matrix [18].  Sensitivity (true positives compared to false negatives) was assessed by 
modelling the proportion of true positive responses in the hospital images with papilloedema, as for 
specificity.  The relationship between patient factors and FPE was assessed by fitting a generalised 
linear model (negative binomial) with continuous measurements (body mass index [BMI], body fat 
percentage, gestational age at birth, birthweight, age, spherical equivalent and BCVA) as covariates 
and gender, ethnicity and maternal social class as factors. 
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Proportions were compared using Pearson’s χ2 test.  The rate of FPE (P) is displayed as the 
proportion of patients who were mistaken as having papilloedema by χ% of raters (Pχ). 
RESULTS 
Prevalence of FPE 
The prevalence of FPE in the ALSPAC population, defined as patients who were mistaken as having 
papilloedema by χ% of raters (Pχ) varied with the value of χ (Fig. 1A).  No patient was incorrectly 
assessed as papilloedema by all raters and only one by >90% of observers (P90=0.67; 95% CI 0-3.7%; 
Fig 2A), whilst 32 patients were incorrectly assessed as PE by 50% of observers (P50=21.3; 95% CI 
14.8-27.9%), a proportion that was not significantly different between the NO, O and N groups.   
In the hospital population, 2 patients were incorrectly assessed as papilloedema by >50%, giving a 
P50 of 7.1 (95% CI 0.9-23.5%; Fig. 1B). 
Sensitivity and specificity papilloedema detection 
Sensitivity for papilloedema detection approached 100%, although one ophthalmologist and two 
neurologists incorrectly labelled the same patient with unilateral disc swelling (Fig. 2B) as without 
papilloedema (sensitivities: NO, 100%; O, 98±2.4%; N, 95±4.7%; ED 100%). 
Specificity for the assessment of papilloedema was lower, with individual specificities ranging from 
42.7-100%, being lowest in the EM physicians (NO, 85±2.0%; O, 90±1.7%; N, 87±2.1%; ED, 53±3.6% 
p<0.001).  Specificity was lower for the ALSPAC than the hospital images (ALSPAC 75±2.2%; hospital 
87±3.1%; p=0.007).   
Consistency of decision-making 
Across all raters and images, there was 72.6% agreement, with a free-marginal kappa of 0.45 (95% CI 
0.4-0.5), indicating a moderate overall consistency between raters.  The free-marginal kappa was 
highest for neurologists (0.70 [95%CI 0.63-0.77]) and lowest for emergency medicine physicians 
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(0.38 [95%CI 0.30-0.46]), with ophthalmologists (0.68 [95%CI 0.61-0.75]) and neuro-
ophthalmologists (0.54 [95%CI 0.46-0.62]) falling in between.  
The agreement of neuro-ophthalmologists and ophthalmologists were lowered by one clinician in 
each group with FPE rates of 0% and 0.5% respectively. 
ALSPAC population 
At age 12-14, 3350 subjects had fundus images available, but these subjects did not differ in terms of 
visual acuity or refractive error from those who attended the study visit but had no available images 
(see Supplementary file, Table 1). 
Compared to the 10,777 subjects in the ALSPAC cohort without available images (including clinic 
attenders and non-attenders), those with available photographs contained 3% more females 
(p=0.003), 1% more white patients, 6% more subjects in social class 1 and 2 (higher socioeconomic 
status; p<0.001) and 1% fewer premature children (p<0.001; see Supplementary file, Table 2).  
Patient factors affecting FPE 
There was no evidence of a relationship between FPE and patient age (p=0.180), gender (p=0.582), 
ethnicity (p=0.215), maternal social class (p=0.824), BMI (p=0.993), body fat percentage (p=0.624), 
gestational age at birth (p=0.548), mother’s age at birth (0.707), birth weight (p=0.545), refraction 
(p=0.212) or BCVA (p=0.651; Fig. 3).  All except one ALSPAC subject were reported as being healthy 
in the subsequent year after the images were taken and that one subject was judged to have 
papilloedema by one ED physician only. 
DISCUSSION 
The P50 rate of FPE in our community-based sample was 21.3%, suggesting a very high potential for 
asymptomatic members of the general population to be referred for papilloedema investigations 
based on fundus photography screening alone. 
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Our sample size calculations suggested that our study had 95% power to detect an FPE rate greater 
than 10%, less than the 21.3% detected, suggesting that we were adequately powered to define this 
prevalence with a precision less than 5%. 
The forced choice task in the absence of clinical information limits the generalisability of the results 
to experienced neuro-ophthalmologists, who are very likely to use additional information to aid their 
decision-making.  However, the finding of apparent papilloedema on fundus examination should 
usually precipitate further investigation, whether additional features are present or not, and less 
experienced and non-medical professionals may be less able to use additional clinical features from 
history and examination in their decision-making: thus in the community or Emergency Department 
setting practitioners often face a forced choice of whether or not to refer. 
Subtle papilloedema is difficult to distinguish from pseudo-papilloedema, and our data do not 
suggest a solution beyond the utility of a second opinion.  Optical coherence tomography (OCT) 
currently has limited utility to differentiate, as increased retinal nerve fibre layer thickness has been 
reported in both papilloedema and pseudo-papilloedema [19, 20].  Fluorescein angiography is most 
sensitive, but is invasive and often not readily available in the community [21].  The clinician may 
also assess spontaneous venous pulsation (SVP) at the optic disc, which strongly suggests that 
papilloedema is absent but is unfortunately less common in eyes with anomalous optic discs [22].  
The rate of FPE may be lower when patients are assessed on a slit lamp or with a direct 
ophthalmoscope, but this was not the case in the FOTO-ED studies, where clinical examination alone 
did not usually help distinguish FPE after fundus photographic screening by neuro-ophthalmologists 
[personal communication – Dr. Beau Bruce, Emory University, Atlanta, GA USA, 2018]. 
In our study, the detection of papilloedema by fundus photography was extremely sensitive, even 
among EM physicians, consistent with previous reports [16, 23-25].  That three raters missed the 
same case of unilateral papilloedema suggests a need to highlight that papilloedema may be 
asymmetric [26].  The exponential reduction in FPE rates with a requirement for increasing 
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agreement, suggests that second and third opinions from ophthalmology or neurology colleagues 
may help differentiate papilloedema from FPE. 
In determining the sensitivity of papilloedema detection, taking the gold standard as clinical 
diagnosis in the hospital patients and questionnaire assessment plus assumed normality in the 
community sample limits generalisability, because one or two missed cases of papilloedema in the 
community or hospital samples would greatly reduce observed sensitivity.  However, we did not 
design the study to assess the sensitivity of fundus photographic screening for ophthalmic 
pathology, which has been previously assessed in the FOTO-ED studies [16, 23-25], which found a 
FPE rate of 2-12.5% after EM physician review of fundus photography in patients for whom fundus 
examination was indicated and a sensitivity for papilloedema detection of 83% or less [16].  These 
studies did not systematically assess the rate of FPE in neuro-ophthalmologists’ image assessments, 
although this was very low [personal communication – Dr. Beau Bruce, Emory University, Atlanta, GA 
USA, 2018].  This difference from our study may reflect different context and approaches (FOTO-ED 
involved real clinical decisions) or that the FOTO-ED neuro-ophthalmologists would all have fallen 
towards the low-FPE end of our panel of raters.   
The agreement among individual physicians on which patients had FPE was moderate to substantial 
(kappa 0.45 -0.7), greater than a previous study, which found a kappa range 0.17–0.43 for non-
fluorescein imaging modalities [21], suggesting common decision-making strategies.  None of our 10 
cases of papilloedema were mild (Frisén 1) in both eyes and we therefore cannot comment on the 
level of agreement between observers on subtle true disc swelling.  However, all FPE cases appeared 
to be no more than subtle papilloedema, so the disagreement between observers was on what 
constituted subtle disc swelling.  
The hospital population had a significantly lower FPE rate (and higher specificity of a papilloedema 
diagnosis) than our community-based sample, though at 7.1%, this still leaves a very high potential 
for the hospital population to be referred for papilloedema investigations.  Possible explanations for 
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this difference include that the community-based cohort were aged 12-14 years, whilst the hospital 
database included predominantly adults.  However, there was no significant effect of age on FPE 
assessment in our data and in a recent study of methods to diagnose papilloedema, FPE was more 
common in patients under 12 years [21], suggesting that our cohort of patients over 12 years should 
not have an age-related increase in the FPE rate.   
Our assumption that the ALSPAC subjects did not have papilloedema was based on the very low 
population rate (<0.01%) and the lack of reported health problems by the subjects’ parents and 
guardians one year later [13, 14].  There were no cases of frank papilloedema in the included cases 
or in any of the other 3350 images viewed by RB and CW whilst preparing the study and there was 
no relationship between FPE and other known associations with papilloedema such as BMI and body 
fat percentage, suggesting that this assumption was sound.  Were this assumption violated, two 
cases of true papilloedema in the community sample would change the observed rate of FPE or 
specificity by only 1.3%.   
The P50 rate of FPE was 21.3±3.9% for the ALSPAC images and 7.1±10.8% for the hospital images, 
suggesting that screening of the general population by fundus imaging has significant potential for 
harm in terms of over-diagnosis of papilloedema with pressure on secondary care services and 
morbidity from investigations and great but unnecessary anxiety caused to patients and families.  
However, the high sensitivity for papilloedema detection in all groups including EM physicians 
supports its targeted use in patients for whom fundus examination is indicated to exclude 
papilloedema. 
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Figure legends 
Figure 1A. FPE rate in the ALSPAC population at different levels of inter-observer agreement (P0-100) 
for all observers and the different specialty groups.  Error bars are 95% confidence intervals.  B. FPE 
rate in the hospital population at different levels of inter-observer agreement (P1-16) for all observers 
and the different specialty groups.  Error bars are 95% confidence intervals. 
Figure 2. Color fundus images. A. ALSPAC photo classified as papilloedema (FPE) by 15/16 clinicians. 
B. Case of asymmetric papilloedema missed by 3 clinicians. 
Figure 3. Scatter charts showing the relationship between FPE and patient factors.  Bubble size 
relates to the number of duplicate points (equal x and y values).  None of the variables showed any 
evidence of a relationship with FPE. A. Body mass index. B. Gestational age at birth. C. Body fat 
percentage. D. Spherical equivalent refraction. E. Birthweight. F. Age at assessment. 
 
 
 
 
 
